Financials Tempus AI, Inc

Equities

TEM

US88023B1035

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 15:15:16 01/07/2024 BST 5-day change 1st Jan Change
33.48 USD -4.33% Intraday chart for Tempus AI, Inc +37.73% 0.00%

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales 1 62.06 188 257.9 320.7 531.8
EBITDA 1 -104.8 -163.5 -214.6 -238.7 -155.8
EBIT 1 -119.8 -186.6 -238.5 -269.1 -189.1
Operating Margin -193.02% -99.23% -92.49% -83.93% -35.56%
Earnings before Tax (EBT) 1 -115 -209.9 -259.2 -289.7 -213.8
Net income 1 -115 -209.9 -259.2 -289.8 -214.1
Net margin -185.23% -111.62% -100.52% -90.38% -40.26%
EPS - -4.033 -4.728 -5.298 -4.201
Free Cash Flow - -140 -122.1 -120.7 -105.9
FCF margin - -74.46% -47.37% -37.63% -19.91%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 01/09/21 01/09/21 27/04/22 25/08/23 20/05/24
1USD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - 130 291
Net Cash position 1 225 262 38.7 - -
Leverage (Debt/EBITDA) - - - -0.5449 x -1.865 x
Free Cash Flow - -140 -122 -121 -106
ROE (net income / shareholders' equity) - -66% -119% 4,797% 113%
ROA (Net income/ Total Assets) - -20.8% -23.2% -28.9% -19.8%
Assets 1 - 1,010 1,116 1,002 1,083
Book Value Per Share - -8.150 -12.80 -17.80 -21.80
Cash Flow per Share - 8.150 4.410 4.790 2.610
Capex 1 17 13.4 11.8 18.4 34.6
Capex / Sales 27.45% 7.14% 4.56% 5.73% 6.51%
Announcement Date 01/09/21 01/09/21 27/04/22 25/08/23 20/05/24
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. TEM Stock
  4. Financials Tempus AI, Inc